Skip to main content
Clinical Trials/NCT05179109
NCT05179109RecruitingNot Applicable

Robotic Versus Laparoscopic Surgery for Severe Deep Endometriosis: a Prospective, Randomized, Controlled Trial

University of Oulu1 site in 1 country70 target enrollmentStarted: October 3, 2022Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
70
Locations
1
Primary Endpoint
NRS (Numeric rating scale) Score for pain

Study Overview

Brief Summary

The objective of this study is to examine whether robot-assisted laparoscopy is superior compared to conventional laparoscopy as regards to patient outcome.

Detailed Description

The objective of this prospective, randomized trial is to examine whether robot-assisted laparoscopy is superior compared to conventional laparoscopy as regards to patient outcome at 6, 12 and 24 months postoperatively, measured by questionnaires concerning the pain symptoms and disease-related quality-of life.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 50 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •ASA (American Society of Anesthesiologists physical status classification) 1-3
  • •Diagnosed deep endometriosis (MRI)
  • •Patient has symptoms
  • •Operative treatment is indicated
  • •Patient is able to give informed consent

Exclusion Criteria

  • •Recurring rectosigmoid endometriosis

Arms & Interventions

Robot-assisted laparoscopy

Experimental

Surgery for deep endometriosis using robot-assisted laparoscopy.

Intervention: Minimally invasive surgery (Procedure)

Conventional laparoscopy

Active Comparator

Surgery for deep endometriosis using conventional laparoscopy.

Intervention: Minimally invasive surgery (Procedure)

Outcomes

Primary Outcomes

NRS (Numeric rating scale) Score for pain

Time Frame: Immediately postoperatively (24 hours) and 6, 12 and 24 months postoperatively

The surgical outcome as regards to pain symptoms (NRS questionnaire), absolute scores and change from baseline for both study groups.

Secondary Outcomes

  • Factors concerning ERAS (Enhanced recovery after surgery)(Up to 7 days (Hospital stay))
  • Cost(Primary hospital stay and 24 months, for both study groups.)
  • Complications(30 days)
  • General 15 dimensional health-related quality-of-life questionnaire(6, 12 and 24 months)
  • Endometriosis-related quality-of-life(6, 12 and 24 months)
  • Intraoperative measures(Up to 300 minutes (intraoperative))
  • Sexual quality-of-life questionnaire(6, 12 and 24 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Sari Koivurova

Assistant Chief of Gynecology

University of Oulu

Study Sites (1)

Loading locations...

Similar Trials